Navigation Links
Orion Health and Cisco Announce New Medical Data Exchange Solution to Integrate, Share and Report Public Health Data
Date:8/31/2009

athy English, director of Cisco Global Healthcare Solutions, notes the Rhapsody solution meets the demands for providers to both transmit reports as well as receive public health notifications in a simple and cost-effective manner. The Rhapsody® AXP utilizes global industry software and hardware open standards to ensure its integration into health information systems, remarked English

Paul Viskovich, Orion Health President of North America and EMEA, anticipates that smaller sites and remote clinics may find this version of Rhapsody particularly useful.

"Rhapsody AXP helps health facilities of any size to contribute to the national preparedness effort by streamlining and automating the process for data exchange using PHIN standards to report to the CDC," continued Mr. Viskovich.

Rhapsody AXP is designed to be deployed with minimal IT resources within a hospital's or clinic's existing reporting system. Cisco Integrated Services Routers with Cisco Application Extension Platform provide a robust and highly secure platform for transmitting and receiving healthcare data.

Rhapsody AXP formats the data and routes it within the hospital or clinic, and between organizations and across regions. This includes the Centers for Disease Control for data sharing and analysis, as well as the detection of patterns of common disease symptoms.

Rhapsody AXP uses standards-based technology to integrate data within a facility and between external partners taking advantage of existing IT investments and systems. Currently the company helps facilities and healthcare communities that connect 35 million patients with tens of thousands of active users.

To learn more about or purchase the Rhapsody AXP solution, contact:
United States: +1 800 905 9151
Canada: +1 877 763 4666
United Kingdom: +44 0870 432 9580
Australia: +61 2 9965 3756
New Zealand: +64 9 638 0600

About Cisco Application Extension P
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services
3. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
4. Orion Health's Dr. Chris Hobson Selected to Speak at World Congress Public Health Conference
5. SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring
6. Orion Health Signs Trinity Design for Japanese Market
7. Successful EHR Programs turn to Orion Health to Solve the Challenge of Interoperability
8. Orion Health Congratulates Wrightington, Wigan and Leigh NHS Foundation Trust on Achieving Community-based Governance
9. Orion Health Concerto Whiteboard Helps Emergency Rooms and Wards Track Patient Status
10. Orion Health Live at Harley Street Clinic
11. Expanding into New Markets with Customer-Focused Solutions, Orion Health Sees Strong Growth
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Orion Health and Cisco Announce New Medical Data Exchange Solution to Integrate, Share and Report Public Health Data
(Date:4/1/2015)... (PRWEB) April 01, 2015 IQ Formulations ... health and nutritional supplement companies in the U.S., today is ... testing and quality control standards for its herbal supplements.* GNC ... supply chain to ensure the accuracy of labeling on its ... veteran and IQ Formulations CEO Jay Cohen said: ...
(Date:4/1/2015)... Sheboygan, WI (PRWEB) April 01, 2015 ... or dryness occur, waiting days or weeks for an ... wants. Historically same and next day appointments haven’t been ... Falls area, Forefront Dermatology’s offices have noticed demand for ... , “We realize how important relief or answers ...
(Date:4/1/2015)... The 2015 Deep Market Research ... professional and in-depth study on the current state ... with a focus on the Chinese situation. , ... are Pfizer, Lek Pharmaceuticals D.D., Dr Reddys Labs ... Limited, Cadila Healthcare Limited, Sandoz Inc, Teva Pharms, ...
(Date:4/1/2015)... The U.S. Department of Health and Human ... who are waiting for a lifesaving organ transplant.” Many ... , In the “Play Through with Erik ... TOUR golfer and two-time heart transplant recipient, raises awareness ... donors. He inspires viewers by reminding them, "You ...
(Date:4/1/2015)... 01, 2015 Natural fertility experts from ... attend the world’s first Integrative Fertility Symposium ( https://ifsymposium.com/ ... Centre (SFU Downtown Campus), 515 West Hastings Street, Vancouver ... Sunday, May 3rd, 3:00 pm to 5:00 pm at ... first of its kind in the world to bring ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 2Health News:Vancouver Hosts the World's First Integrative Fertility Symposium 3
... PHILADELPHIA, July 16 On Wednesday, July 22nd, GlaxoSmithKline ... financial results for the three months ended June 30, 2009. ... London Stock Exchange at approximately 7:00 AM EDT . ... Witty, Chief Executive Officer, Julian Heslop, Chief Financial Officer and Moncef ...
... , CAMBRIDGE, Mass., July 16 Biopure ... filed a voluntary petition for relief under Chapter 11 of the ... the District of Massachusetts. Biopure will continue to manage and ... case, subject to the supervision of the Bankruptcy Court. , ...
... ... just launched on Monday. , ... (Vocus) July 16, 2009 -- The National Practice Transition Network (NPTN), created ... practice sales and appraisals, is the first membership-based, commission-free organization to offer such a menu ...
... WASHINGTON, July 16 The American Society of Hematology (ASH) announces ... awarded at ASH,s annual meeting in December. The inaugural recipients are ... of the University of California - San Francisco. , ... named for the late Dr. Ernest Beutler, past president of ASH ...
... , , DETROIT, July ... companies are looking for alternative options to decrease spending without losing ... quality of coverage for their employees and lower their costs by ... Arrangements (HRA). , , ...
... , SANTA CLARA, Calif., July ... reduction was featured recently in the New York Times Fashion ... of Dermatology New York University Medical Center and Founding Director, ... Dr. Kauvar described the LightSheer Duet as a welcome relief ...
Cached Medicine News:Health News:National Practice Transition Network Launches as the Country's First Membership-Based, Commission-Free Dental Practice Transition Company 2Health News:The American Society of Hematology Announces New Honorific Award 2Health News:How To Reduce Cost Without Sacrificing Your Health Coverage 2Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 2Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 3Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 4Health News:Lumenis' High Speed LightSheer(R) Duet(TM) Featured in New York Times Fashion & Style for Eliminating 'Pain and Nuisance' of Hair Removal for Men 5
(Date:4/1/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... $60.0 million aggregate principal amount of its convertible ... private placement to qualified institutional buyers pursuant to ... as amended (the "Act"). Egalet also granted the ...
(Date:4/1/2015)... April 1, 2015  Salix Pharmaceuticals, Ltd. ("Salix"), ... Inc. (NYSE: VRX ) (TSX:VRX), today announced ... $750,000,000 aggregate principal amount of its 6.00% Senior ... " Notes ") pursuant to two redemptions. On ... principal amount of the Notes, and on May ...
(Date:4/1/2015)... AVIV, Israel , April 1, 2015 /PRNewswire/ ... a clinical-stage biopharmaceutical company focused on the development ... the treatment of liver diseases and cholesterol gallstones, ... Tonelli as Vice President of Clinical Operations. ... progressive experience in clinical operations, development and regulatory ...
Breaking Medicine Technology:Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 2Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations 3
... blood ... flow, muscle oxygen supply, HOBOKEN, N.J., Oct. 17 ... reveals Pycnogenol(R),(pic-noj-en-all), an antioxidant plant extract from the bark of the ... which leads to an increase in blood flow and oxygen supply,to ...
... vs. Drug-Eluting and Bare ... ... TRIAS (TRI-stent Adjudication Study) trial of OrbusNeich,s,Genous Bio-engineered R stent has ... to Robbert de Winter, M.D., Ph.D.,principal investigator and director of the ...
Cached Medicine Technology:New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 2New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production 3Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) 2
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
For the quantitative in vitro determination of Uric Acid in serum, plasma and urine...
For the quantitative in vitro determination of apolipoprotein A-1 (apo A-1) in serum and plasma. For use as an aid if assessing the risk of coronary artery disease....
For the quantitative in vitro determination of Urea in serum, plasma and urine....
Medicine Products: